Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Liaoyuan Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and chemical intermediates. Founded in 1991, the company has established itself as a global leader in the production of antidepressant and antiviral agents, including high-volume products like sertraline, venlafaxine, and entecavir. Liaoyuan operates as a key supplier and CDMO partner for major international pharmaceutical firms, maintaining rigorous GMP standards across its manufacturing facilities. The company's portfolio primarily focuses on central nervous system disorders, infectious diseases, and cardiovascular health. With a strong emphasis on process chemistry and vertical integration, Liaoyuan Pharmaceutical plays a critical role in the global supply chain for essential small molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoyuan.